Infectious diseases. Candidate drug breaks down malaria's walls.
Taubes
Gary
G
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D002794:Choline / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism / Q000469:parasitology*; D000882:Haplorhini; D016778:Malaria, Falciparum / Q000188:drug therapy / Q000469:parasitology; D049990:Membrane Transport Modulators; D026901:Membrane Transport Proteins / Q000037:antagonists & inhibitors; D010743:Phospholipids / Q000096:biosynthesis; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism; D011759:Pyrrolidines / Q000494:pharmacology* / Q000627:therapeutic use
C448986:1,16-hexadecamethylenebis(N-methylpyrrolidinyl); D000962:Antimalarials; D049990:Membrane Transport Modulators; D026901:Membrane Transport Proteins; D010743:Phospholipids; D011759:Pyrrolidines; C065637:choline transporter; D002794:Choline